FIELD: medicine.
SUBSTANCE: method involves measuring a peak thrombin concentration (PTC) and an endogenous thrombin potential (ETP) in thrombin generation test; if PTC is more than 367.91 nmol/l in 6-8 weeks pregnant females; 444.84 nmol/l in 12-13 weeks pregnant females; 479.74 nmol/l in 22-24 weeks pregnant females and 488.06 nmol/l in 34-36 weeks pregnant females, and/or ETP is more than 2164.53 nmol/min in 6-8 weeks pregnant females; 2444.15 nmol/min in 12-13 weeks pregnant females; 3072.34 nmol/min in 22-24 weeks pregnant females and 2849.63 nmol/min in 34-36 weeks pregnant females, the above females are stated to have a high thrombogenic risk and need heparin prevention. The presented method is easy to implement and high-informative.
EFFECT: invention can be used for determining a high thrombogenic risk in the pregnant females in need of heparin prevention, for reducing a rate of venous thromboembolic complications and improving the clinical outcomes of pregnancies.
1 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING ONSET OF PREGNANCY | 2012 |
|
RU2524650C2 |
| METHOD FOR PREDICTION OF RISK OF MALIGNANT GROWTHS IN FEMALE GENITAL ORGANS AND MAMMARY GLANDS | 2014 |
|
RU2578459C1 |
| METHOD OF SELECTING HEPARIN APPLICATION FOR PREVENTION OF THROMBOTIC COMPLICATIONS | 2009 |
|
RU2408288C1 |
| METHOD FOR OPTIMIZING LABORATORY DIAGNOSIS OF THROMBINEMIA IN PATIENTS WITH COVID-19 INFECTION | 2022 |
|
RU2789822C1 |
| METHOD OF PREVENTING THROMBOTIC COMPLICATIONS OF PREGNANCY IN WOMEN WITH NON-DIFFERENTIATED FORMS OF MESENCHYMAL DYSPLASIA | 2012 |
|
RU2514045C2 |
| METHOD OF SCREENING EXAMINATION FOR DETECTION OF RISK GROUPS OF DEVELOPING HYPERCOAGULATION STATE IN CONDITIONS OF EXPEDITIONARY WORK IN THE ARCTIC | 2020 |
|
RU2767891C2 |
| NOVEL COMPOUNDS POSSESSING ANTICOAGULANT FUNCTION, BASED ON THEM PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF THROMBOTIC CONDITIONS AND PLASMA-SUBSTITUTING SOLUTION FOR CORRECTION OF HYPERCOAGULATION DISORDERS IN HEMODILUTION | 2007 |
|
RU2353619C2 |
| METHOD FOR PREDICTION OF SEVERE PREECLAMPSIA IN PREGNANT WOMEN ACCOMPANYING A MUTATION OF THE PROTHROMBIN GENE, GENOTYPE F2G20210A | 2019 |
|
RU2723627C1 |
| METHOD FOR ASSESSMENT OF DYNAMICS AND COMPLETENESS OF CONTRACTION OF BLOOD CLOTS FOR PREDICTION OF PROBABILITY OF SPONTANEOUS ABORTION | 2020 |
|
RU2735988C1 |
| METHOD OF DETERMINING INDICATIONS FOR TRANSFUSION OF PLASMA-COAGULATION HAEMOSTASIS CORRECTORS IN CARDIAC SURGERY | 2014 |
|
RU2568581C1 |
